280 related articles for article (PubMed ID: 17680847)
1. Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer.
Di Fiore F; Lecleire S; Pop D; Rigal O; Hamidou H; Paillot B; Ducrotté P; Lerebours E; Michel P
Am J Gastroenterol; 2007 Nov; 102(11):2557-63. PubMed ID: 17680847
[TBL] [Abstract][Full Text] [Related]
2. Concurrent chemoradiotherapy or endoscopic stenting for advanced squamous cell carcinoma of esophagus: a case-control study.
Wong SK; Chiu PW; Leung SF; Cheung KY; Chan AC; Au-Yeung AC; Griffith JF; Chung SS; Ng EK
Ann Surg Oncol; 2008 Feb; 15(2):576-82. PubMed ID: 18057993
[TBL] [Abstract][Full Text] [Related]
3. Response to definitive chemoradiotherapy and survival in patients with an oesophageal adenocarcinoma versus squamous cell carcinoma: a matched-pair analysis.
Tougeron D; Di Fiore F; Hamidou H; Rigal O; Paillot B; Michel P
Oncology; 2007; 73(5-6):328-34. PubMed ID: 18497505
[TBL] [Abstract][Full Text] [Related]
4. Nonoperable patients with superficial esophageal cancer treated by photodynamic therapy after chemoradiotherapy have more severe complications than patients treated in primary intent.
Lecleire S; Di Fiore F; Antonietti M; Ben-Soussan E; Hochain P; Lerebours E; Michel P; Ducrotté P
Am J Gastroenterol; 2008 Sep; 103(9):2215-9. PubMed ID: 18844614
[TBL] [Abstract][Full Text] [Related]
5. Chemoradiotherapy with and without esophagectomy for advanced esophageal cancer.
Nakamura T; Ota M; Hayashi K; Eguchi R; Ide H; Takasaki K; Mitsuhashi N
Hepatogastroenterology; 2006; 53(71):705-9. PubMed ID: 17086873
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of patients with oesophageal cancer treated with preoperative chemoradiotherapy, followed by tumor resection: influence of nutritional factors.
Zemanova M; Novak F; Vitek P; Pazdro A; Smejkal M; Pazdrova G; Petruzelka L
J BUON; 2012; 17(2):310-6. PubMed ID: 22740211
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor is a possible predictor of sensitivity to chemoradiotherapy in the primary lesion of esophageal squamous cell carcinoma.
Gotoh M; Takiuchi H; Kawabe S; Ohta S; Kii T; Kuwakado S; Katsu K
Jpn J Clin Oncol; 2007 Sep; 37(9):652-7. PubMed ID: 17940077
[TBL] [Abstract][Full Text] [Related]
8. A randomised trial of radiotherapy compared with cisplatin chemo-radiotherapy in patients with unresectable squamous cell cancer of the esophagus.
Kumar S; Dimri K; Khurana R; Rastogi N; Das KJ; Lal P
Radiother Oncol; 2007 May; 83(2):139-47. PubMed ID: 17445928
[TBL] [Abstract][Full Text] [Related]
9. Phase III trial of protracted compared with split-course chemoradiation for esophageal carcinoma: Federation Francophone de Cancerologie Digestive 9102.
Crehange G; Maingon P; Peignaux K; N'guyen TD; Mirabel X; Marchal C; Verrelle P; Roullet B; Bonnetain F; Bedenne L;
J Clin Oncol; 2007 Nov; 25(31):4895-901. PubMed ID: 17971585
[TBL] [Abstract][Full Text] [Related]
10. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.
Miyoshi N; Yano M; Takachi K; Kishi K; Noura S; Eguchi H; Yamada T; Miyashiro I; Ohue M; Ohigashi H; Sasaki Y; Ishikawa O; Doki Y; Imaoka S
J Surg Oncol; 2009 Apr; 99(5):302-6. PubMed ID: 19170110
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness of planned esophagectomy after neoadjuvant chemoradiotherapy for advanced esophageal carcinomas.
Kato H; Fukuchi M; Manda R; Faried A; Takita J; Nakajima M; Miyazaki T; Sohda M; Fukai Y; Masuda N; Tsukada K; Kuwano H
Anticancer Res; 2004; 24(6):4091-6. PubMed ID: 15736457
[TBL] [Abstract][Full Text] [Related]
12. High orotate phosphoribosyltransferase gene expression predicts complete response to chemoradiotherapy in patients with squamous cell carcinoma of the esophagus.
Kajiwara T; Nishina T; Hyodo I; Moriwaki T; Endo S; Nasu J; Hori S; Matsuura B; Hiasa Y; Onji M
Oncology; 2009; 76(5):342-9. PubMed ID: 19307741
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of blood transfusions in patients with esophageal cancer treated with combined chemoradiotherapy.
Kader AS; Lim JT; Berthelet E; Petersen R; Ludgate D; Truong PT
Am J Clin Oncol; 2007 Oct; 30(5):492-7. PubMed ID: 17921709
[TBL] [Abstract][Full Text] [Related]
14. Conformal therapy improves the therapeutic index of patients with anal canal cancer treated with combined chemotherapy and external beam radiotherapy.
Vuong T; Kopek N; Ducruet T; Portelance L; Faria S; Bahoric B; Devic S
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1394-400. PubMed ID: 17276620
[TBL] [Abstract][Full Text] [Related]
15. Undernutrition is predictive of early mortality after palliative self-expanding metal stent insertion in patients with inoperable or recurrent esophageal cancer.
Lecleire S; Di Fiore F; Antonietti M; Ben Soussan E; Hellot MF; Grigioni S; Déchelotte P; Lerebours E; Michel P; Ducrotté P
Gastrointest Endosc; 2006 Oct; 64(4):479-84. PubMed ID: 16996335
[TBL] [Abstract][Full Text] [Related]
16. American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma.
Rizk NP; Venkatraman E; Bains MS; Park B; Flores R; Tang L; Ilson DH; Minsky BD; Rusch VW;
J Clin Oncol; 2007 Feb; 25(5):507-12. PubMed ID: 17290058
[TBL] [Abstract][Full Text] [Related]
17. Low expression of Bax predicts poor prognosis in patients with locally advanced esophageal cancer treated with definitive chemoradiotherapy.
Kang SY; Han JH; Lee KJ; Choi JH; Park JI; Kim HI; Lee HW; Jang JH; Park JS; Kim HC; Kang S; Oh YT; Chun M; Kim JH; Sheen SS; Lim HY
Clin Cancer Res; 2007 Jul; 13(14):4146-53. PubMed ID: 17634542
[TBL] [Abstract][Full Text] [Related]
18. Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer.
Miyata H; Yamasaki M; Takiguchi S; Nakajima K; Fujiwara Y; Nishida T; Mori M; Doki Y
J Surg Oncol; 2009 Nov; 100(6):442-6. PubMed ID: 19653262
[TBL] [Abstract][Full Text] [Related]
19. Definitive chemoradiotherapy in patients with esophageal adenocarcinoma: an alternative to surgery?
Tougeron D; Scotté M; Hamidou H; Di Fiore F; Paillot B; Michot F; Michel P
J Surg Oncol; 2012 Jun; 105(8):761-6. PubMed ID: 22124932
[TBL] [Abstract][Full Text] [Related]
20. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response.
Pourel N; Santelmo N; Naafa N; Serre A; Hilgers W; Mineur L; Molinari N; Reboul F
Eur J Cardiothorac Surg; 2008 May; 33(5):829-36. PubMed ID: 18367406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
